ARTICLE | Company News
AC Immune, Bayer deal
October 12, 2009 7:00 AM UTC
AC Immune will use Bayer's labeled tracer florbetaben to support an ongoing Phase I trial of AC Immune's ACI-24 Alzheimer's disease vaccine. Bayer's Bayer Schering Pharma AG subsidiary will provide ...